Showing results (461-470 of 661) with videos related to
Sort By:
Pageof 67
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2013
Epidemiology of head and neck squamous cell cancer among HIV-infected patientsGypsyamber Dʼsouza, Thomas E Carey, William N William, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2013
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trialAlda L Tam, Edward S Kim, J Jack Lee, et al.Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
LLM-Driven Extraction of NI-RADS and Imaging Tumor Characteristics to Enhance Oropharyngeal Cancer Survivorship SurveillanceWenye Song, Lina Shbita, Isabelle Jia Hui Jang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancerDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural MesotheliomaAnne S Tsao, Heather Lin, Brett W Carter, et al.Proceedings of the National Academy of Sciences of the United States of America|May 6, 2021
Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p lossWilliam N William, Xin Zhao, Joy J Bianchi, et al.Cancer Research|September 10, 2009
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer developmentWoo-Young Kim, Quanri Jin, Seung-Hyun Oh, et al.Nature Communications|September 27, 2016
The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cellsHye-Jin Boo, Hye-Young Min, Hyun-Ji Jang, et al.Oral Oncology|June 19, 2018
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinomaRenata Ferrarotto, William N William, Jennifer E Tseng, et al.JAMA Oncology|December 27, 2019
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysisJianchun Duan, Longgang Cui, Xiaochen Zhao, et al.Pageof 67